Glipq-8mg Vial

GLIPIQ 8mg Injection contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a prescription medicine used for long-term weight management in adults with obesity or overweight along with weight-related health problems. It is given once weekly as a subcutaneous injection. GLIPIQ 8mg Injection is marketed by Glenmark Pharmaceuticals Ltd. It should be used along with a reduced-calorie diet and increased physical activity as advised by the doctor.

GLIPIQ 8mg Injection may be prescribed for: Long-term weight management: It may be used in adults with obesity, defined as a body mass index (BMI) of 30 kg/m² or more. Overweight with weight-related health problems: It may be used in adults with a BMI of 27 kg/m² or more who have conditions such as type 2 diabetes, high blood pressure, or high cholesterol. GLIPIQ should be used along with a suitable diet and regular physical activity. The dose is selected and adjusted by the doctor based on the individual's response and treatment plan.

GLIPIQ 8mg Injection is given once weekly as a subcutaneous injection, exactly as prescribed by your doctor. It can be injected into the abdomen, thigh, or upper arm. Rotate the injection site when possible. Your doctor or healthcare professional should show you how to use the injection correctly before your first dose. It can be administered with or without food. Use GLIPIQ on the same day each week as advised by your doctor.

Common side effects of GLIPIQ 8mg Injection may include: Nausea Vomiting Diarrhoea Constipation Abdominal pain Indigestion Headache Fatigue Bloating or gas These effects are more common when treatment is started or the dose is increased and may improve as the body adjusts. Seek medical attention if you develop severe or persistent abdominal pain, especially if it spreads to the back, as this may be a sign of pancreatitis. Contact your doctor if you develop symptoms that may indicate gallbladder problems, kidney problems, or a serious allergic reaction.

Pregnancy Unsafe GLIPIQ 8mg Injection should not be used during pregnancy. If you become pregnant while using Semaglutide, contact your doctor promptly. Women planning a pregnancy should discuss treatment with their doctor beforehand. Semaglutide should generally be stopped at least 2 months before a planned pregnancy. Breast Feeding Consult Your Doctor Tell your doctor if you are breastfeeding before using GLIPIQ 8mg Injection. Your doctor will decide whether treatment is appropriate based on your individual circumstances. Lungs Consult Your Doctor Semaglutide does not have specific routine lung-related precautions. Tell your doctor about any significant respiratory condition and inform your healthcare team if you are scheduled for surgery or a procedure requiring general anaesthesia or deep sedation. Liver Consult Your Doctor Tell your doctor if you have liver disease before starting GLIPIQ 8mg Injection. Your doctor will decide whether any additional monitoring or treatment adjustments are needed. Alcohol Consult Your Doctor Alcohol may worsen gastrointestinal symptoms such as nausea and vomiting and can contribute to dehydration. If you have diabetes or use medicines that can c

2 - 8°C